Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial. 2009

María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
Liver Research Unit, Hospital Universitario Santa Cristina-CIBERehd, C/Maestro Vives, 2. 28009 Madrid, Spain.

The use of adjuvants capable of improving the deficient immune response to hepatitis B virus (HBV) vaccine in haemodialysis patients is highly needed. Among potential adjuvants, type I interferons deserve a special attention in view of their known effects promoting cellular and humoral immune responses. The aim of the present trial was to evaluate the effects of recombinant interferon-alpha2b (IFN) administered as an adjuvant of HBV vaccine in unvaccinated haemodialysis patients. A significant and early enhancing effect on the antibody response was observed in patients receiving IFN. In addition, a predominance of IgG1 anti-HBs along with a transient normalization of circulating Th1 lymphocytes was only found in patients receiving IFN who achieved an early seroprotection. However, 6 months after the last vaccine dose, no significant differences were observed in the seroprotection rate achieved in patients vaccinated with IFN compared to that in patients receiving HBV vaccine alone. Mild to moderate fever, asthenia, and arthromyalgia were the most common reactions that occurred in vaccinees given IFN. In conclusion, addition of IFN to HBV vaccine, under the conditions used in this trial, is safe and achieves an earlier and higher seroprotection rate improving Th1-dependent immune response in haemodialysis patients.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
January 1994, Journal of gastroenterology and hepatology,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
April 2009, Nephrology (Carlton, Vic.),
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
January 2002, Intervirology,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
April 1986, Singapore medical journal,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
January 2000, The Journal of the Egyptian Public Health Association,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
March 1990, Vaccine,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
July 1990, The International journal of artificial organs,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
July 1991, Journal of medical virology,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
February 1990, Australian and New Zealand journal of medicine,
María E Miquilena-Colina, and Tamara Lozano-Rodríguez, and Leonor García-Pozo, and Alicia Sáez, and Paola Rizza, and Imerio Capone, and Maria Rapicetta, and Paola Chionne, and Maria Capobianchi, and Marina Selleri, and Concetta Castilletti, and Filippo Belardelli, and Oreste Lo Iacono, and Carmelo García-Monzón
January 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
Copied contents to your clipboard!